CBD cream shows promise for eczema itch relief in small study
NCT ID NCT07301658
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This 56-day study tested a cream containing CBD and cherimoya fruit extract on 42 children and adults with mild-to-moderate atopic dermatitis (eczema). Participants applied the cream twice daily. Researchers measured skin redness, dryness, itching, and sleep quality. The goal was to see if the cream could improve skin barrier function and comfort.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cream containing cannabidiol (CBD) and Annona cherimola fruit extract
What this could lead to
If it works, this could offer a gentle, non-drug option to ease itching and dryness for people with mild-to-moderate atopic dermatitis.
What could go wrong
This was a small, completed study with no control group, so results may not be definitive. The cream is a cosmetic product, not a medicine, so benefits may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
i+Med S.Coop.
Vitoria-Gasteiz, Álava, 01510, Spain